世界のRNAi技術市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global RNAi Technologies Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4836 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、RNAi技術の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（腫瘍、眼疾患、呼吸器疾患、肝疾患、その他）、用途別市場規模（研究、治療）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・RNAi技術の市場動向 ・企業の競争状況、市場シェア ・RNAi技術の種類別市場規模と予測2016-2027（腫瘍、眼疾患、呼吸器疾患、肝疾患、その他） ・RNAi技術の用途別市場規模と予測2016-2027（研究、治療） ・RNAi技術の北米市場規模2016-2027（アメリカ、カナダ） ・RNAi技術の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・RNAi技術のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・RNAi技術の中南米市場規模2016-2027（メキシコ、ブラジル） ・RNAi技術の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Alnylam Pharmaceuticals、Benitec Biopharma Ltd、Filmtec Corporation、Ionis Pharmaceuticals、Quark Pharmaceuticals Inc.、RXI Pharmaceuticals、Qiagen、Invitrogen、Ambion） ・結論

RNAi (Ribonucleic Acid Interference) a system in live cells to keep a check on the active genes is the next promising technology in the field of biotechnology. The major classes of RNAi are micro RNA and small interfering RNA. RNAi is said to be the replacement technology for the existing recombinant technology in the field of drug discovery and therapeutics.

Market Analysis and Insights: Global RNAi Technologies Market
The global RNAi Technologies market size is projected to reach US$ 430.3 million by 2027, from US$ 301.3 million in 2020, at a CAGR of 4.8% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global RNAi Technologies market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global RNAi Technologies market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global RNAi Technologies market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global RNAi Technologies market.

Global RNAi Technologies Scope and Market Size
RNAi Technologies market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global RNAi Technologies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Oncology
Ocular Disorders
Respiratory Disorders
Liver Diseases
Other

Segment by Application
Research
Therapeutics

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Alnylam Pharmaceuticals
Benitec Biopharma Ltd
Filmtec Corporation
Ionis Pharmaceuticals
Quark Pharmaceuticals Inc.
RXI Pharmaceuticals
Qiagen
Invitrogen
Ambion

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global RNAi Technologies Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oncology
1.2.3 Ocular Disorders
1.2.4 Respiratory Disorders
1.2.5 Liver Diseases
1.2.6 Other
1.3 Market by Application
1.3.1 Global RNAi Technologies Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Research
1.3.3 Therapeutics
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global RNAi Technologies Market Perspective (2016-2027)
2.2 RNAi Technologies Growth Trends by Regions
2.2.1 RNAi Technologies Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 RNAi Technologies Historic Market Share by Regions (2016-2021)
2.2.3 RNAi Technologies Forecasted Market Size by Regions (2022-2027)
2.3 RNAi Technologies Industry Dynamic
2.3.1 RNAi Technologies Market Trends
2.3.2 RNAi Technologies Market Drivers
2.3.3 RNAi Technologies Market Challenges
2.3.4 RNAi Technologies Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top RNAi Technologies Players by Revenue
3.1.1 Global Top RNAi Technologies Players by Revenue (2016-2021)
3.1.2 Global RNAi Technologies Revenue Market Share by Players (2016-2021)
3.2 Global RNAi Technologies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by RNAi Technologies Revenue
3.4 Global RNAi Technologies Market Concentration Ratio
3.4.1 Global RNAi Technologies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by RNAi Technologies Revenue in 2020
3.5 RNAi Technologies Key Players Head office and Area Served
3.6 Key Players RNAi Technologies Product Solution and Service
3.7 Date of Enter into RNAi Technologies Market
3.8 Mergers & Acquisitions, Expansion Plans

4 RNAi Technologies Breakdown Data by Type
4.1 Global RNAi Technologies Historic Market Size by Type (2016-2021)
4.2 Global RNAi Technologies Forecasted Market Size by Type (2022-2027)

5 RNAi Technologies Breakdown Data by Application
5.1 Global RNAi Technologies Historic Market Size by Application (2016-2021)
5.2 Global RNAi Technologies Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America RNAi Technologies Market Size (2016-2027)
6.2 North America RNAi Technologies Market Size by Type
6.2.1 North America RNAi Technologies Market Size by Type (2016-2021)
6.2.2 North America RNAi Technologies Market Size by Type (2022-2027)
6.2.3 North America RNAi Technologies Market Size by Type (2016-2027)
6.3 North America RNAi Technologies Market Size by Application
6.3.1 North America RNAi Technologies Market Size by Application (2016-2021)
6.3.2 North America RNAi Technologies Market Size by Application (2022-2027)
6.3.3 North America RNAi Technologies Market Size by Application (2016-2027)
6.4 North America RNAi Technologies Market Size by Country
6.4.1 North America RNAi Technologies Market Size by Country (2016-2021)
6.4.2 North America RNAi Technologies Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe RNAi Technologies Market Size (2016-2027)
7.2 Europe RNAi Technologies Market Size by Type
7.2.1 Europe RNAi Technologies Market Size by Type (2016-2021)
7.2.2 Europe RNAi Technologies Market Size by Type (2022-2027)
7.2.3 Europe RNAi Technologies Market Size by Type (2016-2027)
7.3 Europe RNAi Technologies Market Size by Application
7.3.1 Europe RNAi Technologies Market Size by Application (2016-2021)
7.3.2 Europe RNAi Technologies Market Size by Application (2022-2027)
7.3.3 Europe RNAi Technologies Market Size by Application (2016-2027)
7.4 Europe RNAi Technologies Market Size by Country
7.4.1 Europe RNAi Technologies Market Size by Country (2016-2021)
7.4.2 Europe RNAi Technologies Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific RNAi Technologies Market Size (2016-2027)
8.2 Asia-Pacific RNAi Technologies Market Size by Type
8.2.1 Asia-Pacific RNAi Technologies Market Size by Type (2016-2021)
8.2.2 Asia-Pacific RNAi Technologies Market Size by Type (2022-2027)
8.2.3 Asia-Pacific RNAi Technologies Market Size by Type (2016-2027)
8.3 Asia-Pacific RNAi Technologies Market Size by Application
8.3.1 Asia-Pacific RNAi Technologies Market Size by Application (2016-2021)
8.3.2 Asia-Pacific RNAi Technologies Market Size by Application (2022-2027)
8.3.3 Asia-Pacific RNAi Technologies Market Size by Application (2016-2027)
8.4 Asia-Pacific RNAi Technologies Market Size by Region
8.4.1 Asia-Pacific RNAi Technologies Market Size by Region (2016-2021)
8.4.2 Asia-Pacific RNAi Technologies Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America RNAi Technologies Market Size (2016-2027)
9.2 Latin America RNAi Technologies Market Size by Type
9.2.1 Latin America RNAi Technologies Market Size by Type (2016-2021)
9.2.2 Latin America RNAi Technologies Market Size by Type (2022-2027)
9.2.3 Latin America RNAi Technologies Market Size by Type (2016-2027)
9.3 Latin America RNAi Technologies Market Size by Application
9.3.1 Latin America RNAi Technologies Market Size by Application (2016-2021)
9.3.2 Latin America RNAi Technologies Market Size by Application (2022-2027)
9.3.3 Latin America RNAi Technologies Market Size by Application (2016-2027)
9.4 Latin America RNAi Technologies Market Size by Country
9.4.1 Latin America RNAi Technologies Market Size by Country (2016-2021)
9.4.2 Latin America RNAi Technologies Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa RNAi Technologies Market Size (2016-2027)
10.2 Middle East & Africa RNAi Technologies Market Size by Type
10.2.1 Middle East & Africa RNAi Technologies Market Size by Type (2016-2021)
10.2.2 Middle East & Africa RNAi Technologies Market Size by Type (2022-2027)
10.2.3 Middle East & Africa RNAi Technologies Market Size by Type (2016-2027)
10.3 Middle East & Africa RNAi Technologies Market Size by Application
10.3.1 Middle East & Africa RNAi Technologies Market Size by Application (2016-2021)
10.3.2 Middle East & Africa RNAi Technologies Market Size by Application (2022-2027)
10.3.3 Middle East & Africa RNAi Technologies Market Size by Application (2016-2027)
10.4 Middle East & Africa RNAi Technologies Market Size by Country
10.4.1 Middle East & Africa RNAi Technologies Market Size by Country (2016-2021)
10.4.2 Middle East & Africa RNAi Technologies Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Alnylam Pharmaceuticals
11.1.1 Alnylam Pharmaceuticals Company Details
11.1.2 Alnylam Pharmaceuticals Business Overview
11.1.3 Alnylam Pharmaceuticals RNAi Technologies Introduction
11.1.4 Alnylam Pharmaceuticals Revenue in RNAi Technologies Business (2016-2021)
11.1.5 Alnylam Pharmaceuticals Recent Development
11.2 Benitec Biopharma Ltd
11.2.1 Benitec Biopharma Ltd Company Details
11.2.2 Benitec Biopharma Ltd Business Overview
11.2.3 Benitec Biopharma Ltd RNAi Technologies Introduction
11.2.4 Benitec Biopharma Ltd Revenue in RNAi Technologies Business (2016-2021)
11.2.5 Benitec Biopharma Ltd Recent Development
11.3 Filmtec Corporation
11.3.1 Filmtec Corporation Company Details
11.3.2 Filmtec Corporation Business Overview
11.3.3 Filmtec Corporation RNAi Technologies Introduction
11.3.4 Filmtec Corporation Revenue in RNAi Technologies Business (2016-2021)
11.3.5 Filmtec Corporation Recent Development
11.4 Ionis Pharmaceuticals
11.4.1 Ionis Pharmaceuticals Company Details
11.4.2 Ionis Pharmaceuticals Business Overview
11.4.3 Ionis Pharmaceuticals RNAi Technologies Introduction
11.4.4 Ionis Pharmaceuticals Revenue in RNAi Technologies Business (2016-2021)
11.4.5 Ionis Pharmaceuticals Recent Development
11.5 Quark Pharmaceuticals Inc.
11.5.1 Quark Pharmaceuticals Inc. Company Details
11.5.2 Quark Pharmaceuticals Inc. Business Overview
11.5.3 Quark Pharmaceuticals Inc. RNAi Technologies Introduction
11.5.4 Quark Pharmaceuticals Inc. Revenue in RNAi Technologies Business (2016-2021)
11.5.5 Quark Pharmaceuticals Inc. Recent Development
11.6 RXI Pharmaceuticals
11.6.1 RXI Pharmaceuticals Company Details
11.6.2 RXI Pharmaceuticals Business Overview
11.6.3 RXI Pharmaceuticals RNAi Technologies Introduction
11.6.4 RXI Pharmaceuticals Revenue in RNAi Technologies Business (2016-2021)
11.6.5 RXI Pharmaceuticals Recent Development
11.7 Qiagen
11.7.1 Qiagen Company Details
11.7.2 Qiagen Business Overview
11.7.3 Qiagen RNAi Technologies Introduction
11.7.4 Qiagen Revenue in RNAi Technologies Business (2016-2021)
11.7.5 Qiagen Recent Development
11.8 Invitrogen
11.8.1 Invitrogen Company Details
11.8.2 Invitrogen Business Overview
11.8.3 Invitrogen RNAi Technologies Introduction
11.8.4 Invitrogen Revenue in RNAi Technologies Business (2016-2021)
11.8.5 Invitrogen Recent Development
11.9 Ambion
11.9.1 Ambion Company Details
11.9.2 Ambion Business Overview
11.9.3 Ambion RNAi Technologies Introduction
11.9.4 Ambion Revenue in RNAi Technologies Business (2016-2021)
11.9.5 Ambion Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global RNAi Technologies Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oncology
Table 3. Key Players of Ocular Disorders
Table 4. Key Players of Respiratory Disorders
Table 5. Key Players of Liver Diseases
Table 6. Key Players of Other
Table 7. Global RNAi Technologies Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global RNAi Technologies Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global RNAi Technologies Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global RNAi Technologies Market Share by Regions (2016-2021)
Table 11. Global RNAi Technologies Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global RNAi Technologies Market Share by Regions (2022-2027)
Table 13. RNAi Technologies Market Trends
Table 14. RNAi Technologies Market Drivers
Table 15. RNAi Technologies Market Challenges
Table 16. RNAi Technologies Market Restraints
Table 17. Global RNAi Technologies Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global RNAi Technologies Market Share by Players (2016-2021)
Table 19. Global Top RNAi Technologies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in RNAi Technologies as of 2020)
Table 20. Ranking of Global Top RNAi Technologies Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by RNAi Technologies Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players RNAi Technologies Product Solution and Service
Table 24. Date of Enter into RNAi Technologies Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global RNAi Technologies Market Size by Type (2016-2021) (US$ Million)
Table 27. Global RNAi Technologies Revenue Market Share by Type (2016-2021)
Table 28. Global RNAi Technologies Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global RNAi Technologies Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global RNAi Technologies Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global RNAi Technologies Revenue Market Share by Application (2016-2021)
Table 32. Global RNAi Technologies Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global RNAi Technologies Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America RNAi Technologies Market Size by Type (2016-2021) (US$ Million)
Table 35. North America RNAi Technologies Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America RNAi Technologies Market Size by Application (2016-2021) (US$ Million)
Table 37. North America RNAi Technologies Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America RNAi Technologies Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America RNAi Technologies Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe RNAi Technologies Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe RNAi Technologies Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe RNAi Technologies Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe RNAi Technologies Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe RNAi Technologies Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe RNAi Technologies Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific RNAi Technologies Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific RNAi Technologies Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific RNAi Technologies Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific RNAi Technologies Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific RNAi Technologies Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific RNAi Technologies Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America RNAi Technologies Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America RNAi Technologies Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America RNAi Technologies Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America RNAi Technologies Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America RNAi Technologies Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America RNAi Technologies Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa RNAi Technologies Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa RNAi Technologies Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa RNAi Technologies Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa RNAi Technologies Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa RNAi Technologies Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa RNAi Technologies Market Size by Country (2022-2027) & (US$ Million)
Table 64. Alnylam Pharmaceuticals Company Details
Table 65. Alnylam Pharmaceuticals Business Overview
Table 66. Alnylam Pharmaceuticals RNAi Technologies Product
Table 67. Alnylam Pharmaceuticals Revenue in RNAi Technologies Business (2016-2021) & (US$ Million)
Table 68. Alnylam Pharmaceuticals Recent Development
Table 69. Benitec Biopharma Ltd Company Details
Table 70. Benitec Biopharma Ltd Business Overview
Table 71. Benitec Biopharma Ltd RNAi Technologies Product
Table 72. Benitec Biopharma Ltd Revenue in RNAi Technologies Business (2016-2021) & (US$ Million)
Table 73. Benitec Biopharma Ltd Recent Development
Table 74. Filmtec Corporation Company Details
Table 75. Filmtec Corporation Business Overview
Table 76. Filmtec Corporation RNAi Technologies Product
Table 77. Filmtec Corporation Revenue in RNAi Technologies Business (2016-2021) & (US$ Million)
Table 78. Filmtec Corporation Recent Development
Table 79. Ionis Pharmaceuticals Company Details
Table 80. Ionis Pharmaceuticals Business Overview
Table 81. Ionis Pharmaceuticals RNAi Technologies Product
Table 82. Ionis Pharmaceuticals Revenue in RNAi Technologies Business (2016-2021) & (US$ Million)
Table 83. Ionis Pharmaceuticals Recent Development
Table 84. Quark Pharmaceuticals Inc. Company Details
Table 85. Quark Pharmaceuticals Inc. Business Overview
Table 86. Quark Pharmaceuticals Inc. RNAi Technologies Product
Table 87. Quark Pharmaceuticals Inc. Revenue in RNAi Technologies Business (2016-2021) & (US$ Million)
Table 88. Quark Pharmaceuticals Inc. Recent Development
Table 89. RXI Pharmaceuticals Company Details
Table 90. RXI Pharmaceuticals Business Overview
Table 91. RXI Pharmaceuticals RNAi Technologies Product
Table 92. RXI Pharmaceuticals Revenue in RNAi Technologies Business (2016-2021) & (US$ Million)
Table 93. RXI Pharmaceuticals Recent Development
Table 94. Qiagen Company Details
Table 95. Qiagen Business Overview
Table 96. Qiagen RNAi Technologies Product
Table 97. Qiagen Revenue in RNAi Technologies Business (2016-2021) & (US$ Million)
Table 98. Qiagen Recent Development
Table 99. Invitrogen Company Details
Table 100. Invitrogen Business Overview
Table 101. Invitrogen Revenue in RNAi Technologies Business (2016-2021) & (US$ Million)
Table 102. Invitrogen Recent Development
Table 103. Ambion Company Details
Table 104. Ambion Business Overview
Table 105. Ambion RNAi Technologies Product
Table 106. Ambion Revenue in RNAi Technologies Business (2016-2021) & (US$ Million)
Table 107. Ambion Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global RNAi Technologies Market Share by Type: 2020 VS 2027
Figure 2. Oncology Features
Figure 3. Ocular Disorders Features
Figure 4. Respiratory Disorders Features
Figure 5. Liver Diseases Features
Figure 6. Other Features
Figure 7. Global RNAi Technologies Market Share by Application: 2020 VS 2027
Figure 8. Research Case Studies
Figure 9. Therapeutics Case Studies
Figure 10. RNAi Technologies Report Years Considered
Figure 11. Global RNAi Technologies Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global RNAi Technologies Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global RNAi Technologies Market Share by Regions: 2020 VS 2027
Figure 14. Global RNAi Technologies Market Share by Regions (2022-2027)
Figure 15. Global RNAi Technologies Market Share by Players in 2020
Figure 16. Global Top RNAi Technologies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in RNAi Technologies as of 2020
Figure 17. The Top 10 and 5 Players Market Share by RNAi Technologies Revenue in 2020
Figure 18. Global RNAi Technologies Revenue Market Share by Type (2016-2021)
Figure 19. Global RNAi Technologies Revenue Market Share by Type (2022-2027)
Figure 20. North America RNAi Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America RNAi Technologies Market Share by Type (2016-2027)
Figure 22. North America RNAi Technologies Market Share by Application (2016-2027)
Figure 23. North America RNAi Technologies Market Share by Country (2016-2027)
Figure 24. United States RNAi Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada RNAi Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe RNAi Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe RNAi Technologies Market Share by Type (2016-2027)
Figure 28. Europe RNAi Technologies Market Share by Application (2016-2027)
Figure 29. Europe RNAi Technologies Market Share by Country (2016-2027)
Figure 30. Germany RNAi Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France RNAi Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. RNAi Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy RNAi Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia RNAi Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic RNAi Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific RNAi Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific RNAi Technologies Market Share by Type (2016-2027)
Figure 38. Asia-Pacific RNAi Technologies Market Share by Application (2016-2027)
Figure 39. Asia-Pacific RNAi Technologies Market Share by Region (2016-2027)
Figure 40. China RNAi Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan RNAi Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea RNAi Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia RNAi Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India RNAi Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia RNAi Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America RNAi Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America RNAi Technologies Market Share by Type (2016-2027)
Figure 48. Latin America RNAi Technologies Market Share by Application (2016-2027)
Figure 49. Latin America RNAi Technologies Market Share by Country (2016-2027)
Figure 50. Mexico RNAi Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil RNAi Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa RNAi Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa RNAi Technologies Market Share by Type (2016-2027)
Figure 54. Middle East & Africa RNAi Technologies Market Share by Application (2016-2027)
Figure 55. Middle East & Africa RNAi Technologies Market Share by Country (2016-2027)
Figure 56. Turkey RNAi Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia RNAi Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE RNAi Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Alnylam Pharmaceuticals Revenue Growth Rate in RNAi Technologies Business (2016-2021)
Figure 60. Benitec Biopharma Ltd Revenue Growth Rate in RNAi Technologies Business (2016-2021)
Figure 61. Filmtec Corporation Revenue Growth Rate in RNAi Technologies Business (2016-2021)
Figure 62. Ionis Pharmaceuticals Revenue Growth Rate in RNAi Technologies Business (2016-2021)
Figure 63. Quark Pharmaceuticals Inc. Revenue Growth Rate in RNAi Technologies Business (2016-2021)
Figure 64. RXI Pharmaceuticals Revenue Growth Rate in RNAi Technologies Business (2016-2021)
Figure 65. Qiagen Revenue Growth Rate in RNAi Technologies Business (2016-2021)
Figure 66. Invitrogen Revenue Growth Rate in RNAi Technologies Business (2016-2021)
Figure 67. Ambion Revenue Growth Rate in RNAi Technologies Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

---